About Hanall Biopharma
Hanall Biopharma is a company based in Seoul (South Korea) founded in 1973. It operates as a B2B and Licensing and Partnerships. Hanall Biopharma offers products and services including Tanfanercept, Batoclimab, and Immuno-oncology Inhibitor. Hanall Biopharma operates in a competitive market with competitors including Annexon, Nicox, Gyroscope, MeiraGTx and Aldeyra, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hanall Biopharma Co., Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hanall Biopharma
Hanall Biopharma offers a comprehensive portfolio of products and services, including Tanfanercept, Batoclimab, and Immuno-oncology Inhibitor.
Topical treatment for inflammatory eye diseases
Targets autoimmune diseases through FcRn inhibition
Next-generation immune checkpoint inhibitor for cancer
People of Hanall Biopharma
Unlock access to complete
Unlock access to complete
Funding Insights of Hanall Biopharma
Detailed funding history for Hanall Biopharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hanall Biopharma
Investment portfolio details for Hanall Biopharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hanall Biopharma
Detailed financials for Hanall Biopharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hanall Biopharma Comparisons
Peer comparison for Hanall Biopharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hanall Biopharma
Hanall Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Nicox, Gyroscope, MeiraGTx and Aldeyra, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| Locked | Locked | Locked |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| Locked | Locked | Locked |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
|
| Locked | Locked | Locked |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
Detailed competitors of Hanall Biopharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hanall Biopharma
Complete news archive for Hanall Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hanall Biopharma
Hanall Biopharma was founded in 1973.
Hanall Biopharma is headquartered in Seoul, South Korea.
HanAll Biopharma is a global biopharmaceutical company headquartered in South Korea, focusing on innovative therapeutics to address unmet medical needs in areas like ophthalmology, immunology, oncology, and neurology. They conduct research, form partnerships, and manage drug pipelines through licensing agreements and clinical trials. Operating from multiple locations including Seoul, they serve healthcare professionals and patients worldwide by advancing treatments and ensuring drug safety.
Hanall Biopharma's top competitors include Annexon, Alimera Sciences and MeiraGTx.
Hanall Biopharma offers Tanfanercept, Batoclimab, and Immuno-oncology Inhibitor.